How mainstream medicine sees photodynamic therapy in the United Kingdom

JNCCN Journal of the National Comprehensive Cancer Network

Volumn 10, Issue SUPP.2, 2012, Pages

  Bown, Stephen G ^a,b  

^a National Medical Laser Centre   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BILE DUCT CANCER; BRAIN CANCER; CANCER SURVIVAL; CLINICAL TRIAL; CONSULTATION; ESOPHAGUS CANCER; HEAD AND NECK CANCER; HUMAN; LUNG CANCER; MEDICAL SPECIALIST; MOUTH CANCER; OUTCOME ASSESSMENT; PHOTODYNAMIC THERAPY; QUALITY OF LIFE; SHORT SURVEY; UNITED KINGDOM;

EID: 84871239917     PISSN: 15401405     EISSN: 15401413     Source Type: Journal    
DOI: 10.6004/jnccn.2012.0180     Document Type: Short Survey

References (16)

1. Fayter D, Corbett M, Heirs M, et al. A systematic review of photodynamic therapy in the treatment of pre-cancerous skin conditions, Barrett's oesphagus and cancers of the biliary tract, brain, head and neck, lung, oesophagus and skin. Health Technol Assess 2010;14:1-288.
2. Attili SK, Ibbotson SH. How we treat Bowen's disease with topical photodynamic therapy in Dundee. Photodiagnosis Photodyn Ther 2009;6:41-45.
3. Morton CA, McKenna KE, Rhodes LE. Guidelines for topical photodynamic therapy: update. Br J Dermatol 2008;159:1245-1266.
4. Moghissi K, Dixon K, Stringer M, et al. The place of bronchoscopic photodynamic therapy in advanced unresectable lung cancer: experience of 100 cases. Eur J Cardiothorac Surg 1999;15:1-6. (Pubitemid 29084543)
5. Kennedy TC, McWilliams A, Edell E, et al. Bronchial intraepithelial neoplasia/early central airways lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007;132(Suppl):221S-233S. (Pubitemid 47502809)
6. Overholt BF, Lightdale CJ, Wang KK, et al. Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett's esophagus; international, partially blinded, randomized phase III trial. Gastrointest Endosc 2005;62:488-498. (Pubitemid 41383764)
7. Hopper C, Kübler A, Lewis H, et al. mTHPC-mediated photodynamic therapy for early oral squamous cell carcinoma. Int J Cancer 2004;111:138-146. (Pubitemid 38859295)
8. Biel MA. Photodynamic therapy treatment of early oral and laryngeal cancers. Photochem Photobiol 2007;83:1063-1068. (Pubitemid 47438525)
9. Ortner ME, Caca K, Berr F, et al. Successful photodynamic therapy for nonresectable cholangiocarcinoma: a randomized prospective study. Gastroenterology 2003;125:1355-1363. (Pubitemid 37409755)
10. Zoepf T, Jakobs R, Arnold JC, et al. Palliation of nonresectable bile duct cancer: improved survival after photodynamic therapy. Am J Gastroenterol 2005;100:2426-2430.
11. Kahaleh M, Mishra R, Shami VM, et al. Unresectable cholangiocarcinoma: comparison of survival in biliary stenting alone versus stenting with photodynamic therapy. Clin Gastroenterol Hepatol 2008;6:290-297.
12. Matull WR, Dhar DK, Ayaru L, et al. R0 but not R1/R2 resection is associated with better survival than palliative photodynamic therapy in biliary tract cancer. Liver Int 2011;31:99-107.
13. Kiesslich T, Neureiter D, Wolkersdörfer GW, et al. Advances in photodynamic therapy for the treatment of hilar biliary tract cancer. Future Oncol 2010;6:1925-1936.
14. Pereira S, Hughes SK, Roughton M, et al. Photostent-02: porfimer sodium photodynamic therapy plus stenting versus stenting alone in patients (pts) with advanced or metastatic cholangiocarcinomas and other biliary tract tumours (BTC): a multicentre, randomised phase III trial. Presented at the 2010 European Society for Medical Oncology (ESMO) Congress; October 8-12, 2010; Milan, Italy. Abstract 802O.
15. Tomizawa Y, Tian J. Photodynamic therapy for unresectable cholangiocarcinoma. Dig Dis Sci 2012;57:274-283.
16. Eljamel S. Photodynamic applications in brain tumors: a comprehensive review of the literature. Photodiagnosis Photodyn Ther 2010;7:76-85.